A carregar...
Long-Lasting Partial Regression of Glioblastoma Multiforme Achieved by Edotecarin: Case Report
We describe the response to a new chemotherapy agent, topoisomerase I inhibitor edotecarin in an 18-year-old woman with recurring glioblastoma. The therapy was administered for 17 months. The radiological partial response and clinical improvement have been achieved, with minor toxicity. Median survi...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Croatian Medical Schools
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2080410/ https://ncbi.nlm.nih.gov/pubmed/16625697 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|